Akebia Therapeutics, Inc. AKBA
NASDAQ · United States · Health Technology
$0.8650-0.01 (-0.69%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.03 | -0.04 | +28.6% | $49.13M | +0.6% | -27.7%$1.32→$0.95 |
| Q1 2026 | 2026-05-07 | -0.03 | -0.03 | 0.0% | — | — | -21.6%$1.48→$1.16 |
| Q4 2025 | 2026-02-26 | -0.05 | -0.06 | +16.7% | — | — | +8.3%$1.21→$1.31 |
| Q3 2025 | 2025-11-10 | 0.00 | 0.00 | — | — | — | -11.3%$2.04→$1.81 |
| Q2 2025 | 2025-08-07 | 0.00 | -0.02 | +100.0% | — | — | — |
| Q1 2025 | 2025-05-08 | 0.02 | -0.04 | +150.0% | — | — | — |
| Q4 2024 | 2025-03-13 | -0.10 | -0.07 | -42.9% | — | — | — |
| Q2 2024 | 2024-08-08 | -0.04 | -0.05 | +20.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.